Fig. 1

Schematic illustration of the symbiotic mild photothermal-assisted immunotherapy (SMPAI) via a combined all-in-one and all-in-control strategy. aPD-L1/I@LG can trigger a mild temperature rising and activate the systemic immunity to eradicate primary tumors and prevent tumor recurrence and metastasis